Psychiatry

Patient Care Services

Faculty

Grand Rounds

ECT

Substance Abuse

Geriatric Outreach

Research

Research Faculty

Research Staff

Studies Recruiting

Residency Program

for Residents/Applicants

for Medical Students

for Patients & Families

Psychiatry Education Fund

Contact

WFUBMC Home

>

Psychiatry

>

Research

>

Research Faculty

>

Stephen Rapp

Stephen R. Rapp, PhD   Professor and Chief, Psychology Section   Biographical Sketch Dr. Rapp is a tenured Professor and the Chief of the Psychology Section in the Department of Psychiatry and Behavioral Medicine at Wake Forest University School of Medicine. He holds joint appointments in the departments of Public Health Sciences and Dermatology. Dr. Rapp is a Fellow in the American Psychological Association and Gerontological Society of America. Dr. Rapp completed his graduate training as a clinical psychologist at West Virginia University (1978-1982), followed by a clinical internship at the University of Mississippi Medical Center/Jackson VAMC Consortium (1982-1983), and later a National Research Service Postdoctoral Research Fellowship at Yale University School of Medicine (1989-1990). Dr. Rapp was on the faculty at the University of Mississippi Medical Center/Jackson VAMC where he served as the Director of Behavioral Gerontology for 8 years until joining the faculty at Wake Forest University School of Medicine in 1990. Dr. Rapp’s current research interests bridge geropsychology and health psychology. Department Name:   Psychiatry and Behavioral Medicine Office Phone:   (336) 716-6995 Fax:   (336) 716-6830 Email:   srapp@wfubmc.edu       Education     Postgraduate:   Bradley University, M.A.     West Virginia University, Ph.D. Postdoctoral Fellowship:   Yale University School of Medicine       Research Interests     Clinical trials to reduce cognitive impairments Psychosocial impact of disease states Health-related quality of life       Relevant Publications     Snitz B, Saxton J, Fitzpatrick A, Rapp SR, et al. Identifying mild cognitive impairment at baseline in the Gingko Evaluation of Memory (GEM) study. Aging and Mental Health, in press. Butler J, Case LD, Atkins J, Frizell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp SR Stieber V, Shaw EG. A Phase III double blind placebo controlled prospective randomized clinical trial of effect of d-threo-methylphenidate HCL (d-MPH) on quality of life in brain tumor patients receiving radiation. International J Radiation Clin Oncology, Biology and Physics. 2007;69:1496-1501. Hendrix S, Wassertheil-Smoller  S, Johnson KC, Howard BV, Kooerberg C, Rousouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington DM, Lynch J, Rapp SR, Torner J. Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation. 2006; 113:2425-2434. Resnick S, Espeland M, Rapp SR et al.  Effects of combination estrogen with progestin hormone treatment on cognition and affect. J Clin Endocrinology and Metabolism, 2006;19:1802-1810. Rapp SR, Brenes G, Bennett M, Feldman SR, Fleischer A, Graham G, Dailey M.  The Acne Quality of Life Index (Acne QOLI): Development and validation of a brief instrument.  Am J Clinical Dermatology, 2006;7:1-8. Shaw EG, Rosdahl R, D’Agostino RB, Lovato J, Naughton MJ, Robbins ME, Rapp SR. A Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood and quality of life. Journal of Clinical Oncology, 2006; 24:1415-20. Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, Kuller L. Statins and cognitive function in the elderly: The Cardiovascular Health Study. Neurology, 2005 Nov 8; 65:1388-1394. Espeland MA, Gu L, Masaki KH, Langer RD, Coker LH, Stefanick ML, Ockene J, Rapp SR. Association between reported alcohol intake and cognition: Results from the Women’s Health Initiative Memory Study. Am J Epidemiology, 2005; 161:228-238. Rapp DA, Brenes G, Feldman SR, Fleischer A, Graham G., Dailey M & Rapp SR.  Trait anger and acne: Implications for quality of life and clinical care. Br J Dermatology, 2004; 51:183-9. Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B, Hsia J, Margolis K, Hogan P, Wallace R, Dailey M, Freeman R, Hays J. Effects of conjugated equine estrogens on global cognitive function in postmenopausal women: results from the women’s health initiative memory study, JAMA, 2004; 291:2959-2968. Resnick S, Maki P, Zonderman A, Rapp SR, Espeland M, Coker L, Shumaker S. The Women’s Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clinical Trials, 2004; 1:440-450. Rapp DA, Brenes G, Feldman SR, Fleischer A, Graham G., Dailey M & Rapp SR. Trait anger and acne: Implications for quality of life and clinical care. Br J Dermatology, 2004; 51:183-9. Feldman SR, Ligouri A, Kucenic M, Rapp SR, Fleischer AB, Lang W, Kaur M. Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Derm, 2004; 51:45-51. Rapp SR & Feldman SR. The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life. Dermatology Therapy, 2004; 17:376-382. Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B, Hsia J, Margolis K, Hogan P, Wallace R, Dailey M, Freeman R, Hays J. Effects of conjugated equine estrogens on global cognitive function in postmenopausal women: results from the women’s health initiative memory study, JAMA, 2004;291:2959-2968. Shumaker S, Legault C, Kuller L, Rapp S, Thal L, Lane D, Fillit H, Stafanick M, Hendrix S, Langer R, Lewis C, Masaki K, Coker L. Conjugated equine estrogen alone, pooled hormone therapy, and incidence of probable dementia and mild cognitive impairment in postmenopausal women: results from the women’s health initiative memory study. JAMA, 2004; 291:2947-2958. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study. JAMA, May 2003;289:2651-2662. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass MLS, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D. The effect of estrogen plus progestin on global cognitive function in postmenopausal women: Results from the Women’s Health Initiative Memory Study. JAMA, May 2003; 289:2663-2672. Rapp SR, Brenes G, Marsh AP. Memory enhancement training for older adults with mild cognitive impairment: A preliminary study. Aging and Mental Health, 2002; 6:5-11. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin D. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-407. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN. The Women’s Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Controlled Clinical Trials 1998; 19:604-621. Leary MR, Rapp SR, Herbst KC, Exum L, Feldman, SR. Interpersonal concerns and psychological difficulties of psoriasis patients: Effects of disease severity and fear of negative evaluations. Health Psychology 1998;17:530-536. Rapp SR, Exum ML, Reboussin, DM, Feldman SR, Fleischer A, Clark AR. The physical, psychological and social impact of psoriasis. J Health Psychology, 1997;2:525-537.